This Article Full Text Full Text (PDF) All Versions of this Article: 106/13/1722    most recent 01.CIR.0000029923.57048.61v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, Y. Articles by Nakao, K. Search for Related Content PubMed PubMed Citation Articles by Li, Y. Articles by Nakao, K. Related Collections ACE/Angiotension receptors

(Circulation. 2002;106:1722.)
© 2002 American Heart Association, Inc.

Basic Science Reports

Guanylyl Cyclase-A Inhibits Angiotensin II Type 1A Receptor-Mediated Cardiac Remodeling, an Endogenous Protective Mechanism in the Heart

Yuhao Li, MD, PhD; Ichiro Kishimoto, MD, PhD; Yoshihiko Saito, MD, PhD; Masaki Harada, MD, PhD; Koichiro Kuwahara, MD, PhD; Takehiko Izumi, MD; Nobuki Takahashi, MD; Rika Kawakami, MD; Keiji Tanimoto, MD; Yasuaki Nakagawa, MD; Michio Nakanishi, MD; Yuichiro Adachi, PhD; David L. Garbers, PhD; Akiyoshi Fukamizu, PhD; Kazuwa Nakao, MD, PhD

From the Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan; the Howard Hughes Medical Institute and Department of Pharmacology, University of Texas, Southwestern Medical Center at Dallas (D.L.G.); and the Center for Tsukuba Advanced Research Alliance, Institute of Applied Biochemistry, University of Tsukuba, Tsukuba, Ibaraki, Japan (A.F.).

Correspondence to Yoshihiko Saito, 840 Shijo-cho, Kashihara, Nara, 834-8521, Japan. E-mail yssaitu{at}naramed-u.ac.jp

Background— Guanylyl cyclase (GC)-A, a natriuretic peptide receptor, lowers blood pressure and inhibits the growth of cardiac myocytes and fibroblasts. Angiotensin II (Ang II) type 1A (AT_1A), an Ang II receptor, regulates cardiovascular homeostasis oppositely. Disruption of GC-A induces cardiac hypertrophy and fibrosis, suggesting that GC-A protects the heart from abnormal remodeling. We investigated whether GC-A interacts with AT_1A signaling in the heart by target deletion and pharmacological blockade or stimulation of AT_1A in mice.

Methods and Results— We generated double-knockout (KO) mice for GC-A and AT_1A by crossing GC-A-KO mice and AT_1A-KO mice and blocked AT₁ with a selective antagonist, CS-866. The cardiac hypertrophy and fibrosis of GC-A-KO mice were greatly improved by deletion or pharmacological blockade of AT_1A. Overexpression of mRNAs encoding atrial natriuretic peptide, brain natriuretic peptide, collagens I and III, transforming growth factors ß₁ and ß₃, were also strongly inhibited. Furthermore, stimulation of AT_1A by exogenous Ang II at a subpressor dose significantly exacerbated cardiac hypertrophy and dramatically augmented interstitial fibrosis in GC-A-KO mice but not in wild-type animals.

Conclusions— These results suggest that cardiac hypertrophy and fibrosis of GC-A-deficient mice are partially ascribed to an augmented cardiac AT_1A signaling and that GC-A inhibits AT_1A signaling-mediated excessive remodeling.

Key Words: natriuretic peptides • angiotensin • receptors • heart diseases • remodeling

This article has been cited by other articles:

				D. J. Glenn, D. Rahmutula, M. Nishimoto, F. Liang, and D. G. Gardner Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism Cardiovasc Res, November 1, 2009; 84(2): 209 - 217. [Abstract] [Full Text] [PDF]

				L. He, Y. Qi, X. Rong, J. Jiang, Q. Yang, J. Yamahara, M. Murray, and Y. Li The Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: suppression of angiotensin II/AT1 signaling Evid. Based Complement. Altern. Med., August 25, 2009; (2009) nep095v1. [Abstract] [Full Text] [PDF]

				Y. Li, Y. Saito, K. Kuwahara, X. Rong, I. Kishimoto, M. Harada, Y. Adachi, M. Nakanishi, H. Kinoshita, M. Horiuchi, et al. Guanylyl Cyclase-A Inhibits Angiotensin II Type 2 Receptor-Mediated Pro-Hypertrophic Signaling in the Heart Endocrinology, August 1, 2009; 150(8): 3759 - 3765. [Abstract] [Full Text] [PDF]

				S. Yasuno, S. Usami, K. Kuwahara, M. Nakanishi, Y. Arai, H. Kinoshita, Y. Nakagawa, M. Fujiwara, M. Murakami, K. Ueshima, et al. Endogenous cardiac natriuretic peptides protect the heart in a mouse model of dilated cardiomyopathy and sudden death Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1804 - H1810. [Abstract] [Full Text] [PDF]

				M. Mitsuishi, K. Miyashita, A. Muraki, and H. Itoh Angiotensin II Reduces Mitochondrial Content in Skeletal Muscle and Affects Glycemic Control Diabetes, March 1, 2009; 58(3): 710 - 717. [Abstract] [Full Text] [PDF]

				T. Tokudome, I. Kishimoto, T. Horio, Y. Arai, D. O. Schwenke, J. Hino, I. Okano, Y. Kawano, M. Kohno, M. Miyazato, et al. Regulator of G-Protein Signaling Subtype 4 Mediates Antihypertrophic Effect of Locally Secreted Natriuretic Peptides in the Heart Circulation, May 6, 2008; 117(18): 2329 - 2339. [Abstract] [Full Text] [PDF]

				E. Vellaichamy, D. Zhao, N. Somanna, and K. N. Pandey Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy Physiol Genomics, October 19, 2007; 31(2): 193 - 202. [Abstract] [Full Text] [PDF]

				A. Kilic, A. Bubikat, B. Gassner, H. A. Baba, and M. Kuhn Local Actions of Atrial Natriuretic Peptide Counteract Angiotensin II Stimulated Cardiac Remodeling Endocrinology, September 1, 2007; 148(9): 4162 - 4169. [Abstract] [Full Text] [PDF]

				K. B. Margulies and J. C. Burnett Jr Visualizing the Basis for Paracrine Natriuretic Peptide Signaling in Human Heart Circ. Res., July 21, 2006; 99(2): 113 - 115. [Full Text] [PDF]

				J. B. Patel, M. L. Valencik, A. M. Pritchett, J. C. Burnett Jr., J. A. McDonald, and M. M. Redfield Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H777 - H784. [Abstract] [Full Text] [PDF]

				M. Nakanishi, Y. Saito, I. Kishimoto, M. Harada, K. Kuwahara, N. Takahashi, R. Kawakami, Y. Nakagawa, K. Tanimoto, S. Yasuno, et al. Role of Natriuretic Peptide Receptor Guanylyl Cyclase-A in Myocardial Infarction Evaluated Using Genetically Engineered Mice Hypertension, August 1, 2005; 46(2): 441 - 447. [Abstract] [Full Text] [PDF]

				T. Tokudome, T. Horio, I. Kishimoto, T. Soeki, K. Mori, Y. Kawano, M. Kohno, D. L. Garbers, K. Nakao, and K. Kangawa Calcineurin-Nuclear Factor of Activated T Cells Pathway-Dependent Cardiac Remodeling in Mice Deficient in Guanylyl Cyclase A, a Receptor for Atrial and Brain Natriuretic Peptides Circulation, June 14, 2005; 111(23): 3095 - 3104. [Abstract] [Full Text] [PDF]

				A. Bubikat, L. J. De Windt, B. Zetsche, L. Fabritz, H. Sickler, D. Eckardt, A. Godecke, H. A. Baba, and M. Kuhn Local Atrial Natriuretic Peptide Signaling Prevents Hypertensive Cardiac Hypertrophy in Endothelial Nitric-oxide Synthase-deficient Mice J. Biol. Chem., June 3, 2005; 280(22): 21594 - 21599. [Abstract] [Full Text] [PDF]

				M. Kuhn, M. Voss, D. Mitko, J. Stypmann, C. Schmid, N. Kawaguchi, F. Grabellus, and H. A. Baba Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure Cardiovasc Res, November 1, 2004; 64(2): 308 - 314. [Abstract] [Full Text] [PDF]

				H. Tsuneyoshi, T. Nishina, T. Nomoto, H. Kanemitsu, R. Kawakami, O. Unimonh, K. Nishimura, and M. Komeda Atrial Natriuretic Peptide Helps Prevent Late Remodeling After Left Ventricular Aneurysm Repair Circulation, September 14, 2004; 110(11_suppl_1): II-174 - II-179. [Abstract] [Full Text] [PDF]

				G. Selvetella, E. Hirsch, A. Notte, G. Tarone, and G. Lembo Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence Cardiovasc Res, August 15, 2004; 63(3): 373 - 380. [Abstract] [Full Text] [PDF]

				X.-J. Du Gender modulates cardiac phenotype development in genetically modified mice Cardiovasc Res, August 15, 2004; 63(3): 510 - 519. [Abstract] [Full Text] [PDF]

				L. R. Potter CNP, Cardiac Natriuretic Peptide? Endocrinology, May 1, 2004; 145(5): 2129 - 2130. [Full Text] [PDF]

				A. M. Kapoun, F. Liang, G. O'Young, D. L. Damm, D. Quon, R. T. White, K. Munson, A. Lam, G. F. Schreiner, and A. A. Protter B-Type Natriuretic Peptide Exerts Broad Functional Opposition to Transforming Growth Factor-{beta} in Primary Human Cardiac Fibroblasts: Fibrosis, Myofibroblast Conversion, Proliferation, and Inflammation Circ. Res., March 5, 2004; 94(4): 453 - 461. [Abstract] [Full Text] [PDF]

				Y. Li, I. Kishimoto, Y. Saito, M. Harada, K. Kuwahara, T. Izumi, I. Hamanaka, N. Takahashi, R. Kawakami, K. Tanimoto, et al. Androgen Contributes to Gender-Related Cardiac Hypertrophy and Fibrosis in Mice Lacking the Gene Encoding Guanylyl Cyclase-A Endocrinology, February 1, 2004; 145(2): 951 - 958. [Abstract] [Full Text] [PDF]

				D. Wang, S. Oparil, J. A. Feng, P. Li, G. Perry, L. B. Chen, M. Dai, S. W.M. John, and Y.-F. Chen Effects of Pressure Overload on Extracellular Matrix Expression in the Heart of the Atrial Natriuretic Peptide-Null Mouse Hypertension, July 1, 2003; 42(1): 88 - 95. [Abstract] [Full Text] [PDF]